Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00318981 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD
A Phase 4 study of Adult ADHD, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00318981: Completed Phase 4 study of Adult ADHD, sponsored by University of Maryland, College Park.
NCT00318981 is a Phase 4 study of Adult ADHD that has completed, run by University of Maryland, College Park. The registered enrollment target is 40 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00318981, a Phase 4 study of Adult ADHD, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study involves a 7 week dose-response trial of Concerta™ methylphenidate for mothers of children with ADHD who have ADHD themselves. The aim of this study is to assess the efficacy of Concerta™ in improving adult ADHD symptoms and impairments (primary outcome), as well as observed and reported parenting (secondary outcome). The researchers hypothesize that Concerta™ will significantly decrease mothers ADHD symptoms and impairment, as well as improve observed and reported parenting
Conditions Studied
Interventions
- DRUG Concerta
Study Locations (1)
Virginia
- Children's National Medical Center Regional Outpatient Center - Fairfax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-12 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
What the finished NCT00318981 record still lists
NCT00318981 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Adult ADHD appearing as the primary indexed condition, and to 1 intervention - of which Concerta is the first listed.
NCT00318981 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT00318981 about?
NCT00318981 is a clinical study titled "Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD". This study involves a 7 week dose-response trial of Concerta™ methylphenidate for mothers of children with ADHD who have ADHD themselves. The aim of this study is to assess the efficacy of Concerta™ in improving adult ADHD symptoms and impairments (primary outcome), as well as observed and reported ...
What is the current status of trial NCT00318981?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2004-12. Estimated completion is 2006-12.
What conditions does trial NCT00318981 study?
This clinical trial studies the following conditions: Adult ADHD.
What interventions are being tested in trial NCT00318981?
The interventions under investigation include: Concerta (DRUG).
Who is sponsoring clinical trial NCT00318981?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00318981 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00318981's enrollment target sits among peer trials
40 1397th of 2000 higher than 533 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia